XYNOS KONSTANTINOS (Chief Medical Officer) received a stock award from REPLIMUNE GROUP, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2025ACC: 0001104659-25-031832
Officer· Chief Medical Officer
Since Dec 2022
+112.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
112.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
41.0%
4/1/2025
109.89K→154.88K
Total
Net shares
+45K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2025 | A · Award | +45K | — | — | 41.0% | 109.89K | 154.88K |
| Total | +45K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
67.50K shares
Shares
+67.50K
Strike price
8.40
Held after
67.50K
Exercisable
—
4/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock67.50K shares | 4/1/2025 | A · Award | +67.50K | 8.40 | — | 67.50K |